+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antifungal Drugs for Skin Market - Global Forecast 2026-2032- Product Image
Antifungal Drugs for Skin Market - Global Forecast 2026-2032- Product Image
Sale

Antifungal Drugs for Skin Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6135715
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antifungal Drugs for Skin Market is projected to reach USD 5.99 Billion in 2026. It is expected to continue growing at a CAGR of 6.85%, reaching USD 8.88 Billion by 2032.

Antifungal Drugs for Skin: Executive Summary

Antifungal drugs for skin are used to treat superficial fungal infections affecting the skin, feet, groin, nails, and related areas. The therapeutic landscape includes topical creams, ointments, powders, sprays, solutions, and shampoos, alongside oral medicines for selected or extensive infections. Clinical decision-making depends on the suspected organism, infection site, severity, recurrence, patient age, comorbidities, and risk of drug interactions.

Treatment Is Shifting Toward Targeted, Convenient Care

The landscape is being reshaped by stronger emphasis on accurate diagnosis, shorter and simpler treatment routines, and improved adherence. Topical formulations remain important for localized disease, while oral therapy is generally reserved for circumstances in which topical treatment is inadequate or inappropriate. Combination approaches, clearer patient instructions, improved packaging, and pharmacist involvement can help address incomplete courses and recurrent symptoms. Antimicrobial stewardship is also encouraging more selective use of systemic therapy and greater attention to distinguishing fungal infection from dermatitis, bacterial disease, and other look-alike conditions.

Artificial Intelligence Supports Diagnosis, Adherence, and Development

Artificial intelligence can contribute to this field through image-assisted assessment, clinical decision support, treatment-response monitoring, and analysis of patient-reported symptoms. These tools may help identify cases that warrant confirmatory testing or professional review, but they do not eliminate the need for clinical examination and, where appropriate, microscopy, culture, or other diagnostic methods. In research and development, artificial intelligence can support compound screening, formulation optimization, safety-signal detection, and trial recruitment. Implementation should prioritize validated datasets, transparent performance measures, privacy protection, and safeguards against inappropriate self-diagnosis or unnecessary antifungal use.

Regional Dynamics Reflect Access, Climate, and Care Pathways

North America combines broad access to over-the-counter topical products with established dermatology and primary-care services, while Europe places strong emphasis on evidence-based prescribing, pharmacy access, and regulatory consistency across markets. Asia-Pacific includes diverse healthcare systems and climates, with humid conditions and uneven access to diagnosis influencing treatment needs. Latin America is shaped by variable availability of medicines, primary-care capacity, and affordability considerations. In the Middle East, climate, population mobility, and differences in health-system organization affect diagnosis and treatment continuity. Africa faces substantial variation in diagnostic access, medicine availability, and healthcare infrastructure, making practical formulations, trained frontline providers, and reliable supply particularly important.

ASEAN, BRICS, EU, G7, GCC, and NATO Show Distinct Priorities

ASEAN members share regional concerns related to tropical or humid environments, varied regulatory systems, and uneven access to dermatology services, while BRICS countries span large and diverse populations with differing manufacturing, distribution, and primary-care capabilities. The European Union benefits from regulatory coordination but still must address differences in national reimbursement and healthcare delivery. G7 countries generally have stronger diagnostic infrastructure and established stewardship frameworks, although access, adherence, and aging-related care needs remain relevant. GCC health systems commonly combine advanced urban services with high mobility and climatic exposure, making continuity of care important. NATO members encompass varied health systems, so the group is better understood through shared resilience, procurement, and preparedness considerations than through a single treatment model.

Country Priorities Range from Access and Diagnosis to Stewardship

Australia’s geographically dispersed population makes pharmacy access, telehealth, and supply continuity valuable. Brazil and Mexico require approaches that account for regional disparities in healthcare access and medicine distribution. Canada and the United States combine strong clinical capabilities with attention to affordability, appropriate self-care, and antimicrobial stewardship. China and India have large, diverse care networks in which product quality, diagnosis, and access differ across urban and rural settings. France, Germany, Italy, Spain, and the United Kingdom emphasize evidence-based treatment, regulated medicines, and coordinated primary and specialist care, while continuing to address adherence and appropriate escalation. Japan and South Korea have advanced healthcare infrastructures and aging populations, supporting demand for convenient, well-tolerated treatments. Russia’s market environment is influenced by healthcare access, distribution reliability, and regional variation in clinical services.

Industry Leaders Should Prioritize Diagnosis, Adherence, and Responsible Access

Leaders should strengthen evidence for product effectiveness across infection sites and patient groups, support clear labeling, and design formulations that fit real-world routines. Investment in diagnostic education, pharmacist and primary-care training, and referral pathways can reduce inappropriate treatment of nonfungal conditions. Digital adherence tools and carefully validated image-assistance technologies may improve follow-through when used with professional oversight. Supply planning should account for regional access gaps, while stewardship programs should discourage unnecessary systemic treatment. Partnerships with healthcare providers and public-health organizations can help expand responsible access without encouraging indiscriminate self-medication.

Research Methodology for the Executive Summary

This summary uses the supplied market scope-antifungal drugs for skin-and organizes the assessment across treatment trends, artificial-intelligence applications, regions, country groups, and specified countries. Findings are framed from established clinical and healthcare-system considerations, including formulation type, diagnostic practice, adherence, access, stewardship, regulation, and distribution. The analysis deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons. Regional and group narratives reflect structural differences in climate, health-system capacity, regulation, affordability, and care delivery rather than numerical rankings.

The Market’s Strategic Focus Is Better Care, Not Simply More Treatment

The antifungal-drug landscape for skin is moving toward more accurate diagnosis, convenient treatment, responsible access, and stronger continuity of care. Regional and country differences mean that successful strategies must be adapted to local health systems, climate, distribution, and patient behavior. Artificial intelligence can add value when validated and clinically governed, but fundamental priorities remain dependable medicines, appropriate prescribing, patient education, and timely professional review for persistent or severe disease.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Antifungal Drugs for Skin Market, by Drug Class
7.1. Introduction
7.2. Allylamines
7.3. Azoles
7.3.1. Imidazoles
7.3.2. Triazoles
7.4. Polyenes
8. Antifungal Drugs for Skin Market, by Dosage Form
8.1. Introduction
8.2. Cream
8.3. Gel
8.4. Ointment
8.5. Powder
8.6. Spray
9. Antifungal Drugs for Skin Market, by Product Type
9.1. Introduction
9.2. Over The Counter
9.3. Prescription
10. Antifungal Drugs for Skin Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Antifungal Drugs for Skin Market, by Indication
11.1. Introduction
11.2. Tinea Corporis
11.3. Tinea Cruris
11.4. Tinea Pedis
12. Antifungal Drugs for Skin Market, by Route Of Administration
12.1. Introduction
12.2. Oral
12.3. Topical
13. Antifungal Drugs for Skin Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Antifungal Drugs for Skin Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Antifungal Drugs for Skin Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Astellas Pharma Inc
17.3. Bausch Health Companies Inc
17.4. Bayer AG
17.5. Cipla Ltd
17.6. Dr. Reddy’s Laboratories Ltd
17.7. GlaxoSmithKline plc
17.8. Merck & Co Inc
17.9. Novartis AG
17.10. Pfizer Inc
17.11. Sandoz International GmbH
17.12. Sanofi S.A.
17.13. Sun Pharmaceutical Industries Ltd
17.14. Teva Pharmaceutical Industries Ltd
17.15. Viatris Inc
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Antifungal Drugs for Skin Market, Years Considered for the Study
FIGURE 2. Global Antifungal Drugs for Skin Market, Research Design
FIGURE 3. Global Antifungal Drugs for Skin Market, Research Framework
FIGURE 4. Global Antifungal Drugs for Skin Market, Data Triangulation
FIGURE 5. Global Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Antifungal Drugs for Skin Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 7. Global Antifungal Drugs for Skin Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Antifungal Drugs for Skin Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Antifungal Drugs for Skin Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Antifungal Drugs for Skin Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 11. Global Antifungal Drugs for Skin Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Antifungal Drugs for Skin Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Antifungal Drugs for Skin Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Antifungal Drugs for Skin Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 15. Global Antifungal Drugs for Skin Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Antifungal Drugs for Skin Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 17. Global Antifungal Drugs for Skin Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Antifungal Drugs for Skin Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Antifungal Drugs for Skin Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Antifungal Drugs for Skin Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Antifungal Drugs for Skin Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Antifungal Drugs for Skin Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Antifungal Drugs for Skin Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Antifungal Drugs for Skin Market Segmentation & Coverage
TABLE 2. Global Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 3. Global Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 4. Global Allylamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Allylamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Allylamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Azoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Azoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Azoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Imidazoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Imidazoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Imidazoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Triazoles Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Triazoles Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Triazoles Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Polyenes Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Polyenes Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Polyenes Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 20. Global Cream Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cream Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cream Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Gel Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Gel Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Gel Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Ointment Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Ointment Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Ointment Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Spray Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Spray Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Spray Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 36. Global Over The Counter Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Over The Counter Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Over The Counter Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Prescription Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Prescription Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Prescription Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 43. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 53. Global Tinea Corporis Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Tinea Corporis Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Tinea Corporis Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Tinea Cruris Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Tinea Cruris Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Tinea Cruris Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Tinea Pedis Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Tinea Pedis Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Tinea Pedis Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 63. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 78. North America Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. North America Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 80. North America Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 81. North America Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 82. North America Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 83. North America Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. North America Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 85. North America Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 86. Latin America Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Latin America Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 88. Latin America Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 89. Latin America Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 90. Latin America Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 91. Latin America Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 92. Latin America Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 93. Latin America Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 94. Europe Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Europe Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 96. Europe Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 97. Europe Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 98. Europe Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Europe Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Europe Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 101. Europe Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 102. Middle East Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Middle East Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 104. Middle East Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 105. Middle East Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 106. Middle East Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. Middle East Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. Middle East Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 109. Middle East Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 110. Africa Antifungal Drugs for Skin Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Africa Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 112. Africa Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 113. Africa Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 114. Africa Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. Africa Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. Africa Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 117. Africa Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 118. Global Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. ASEAN Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. ASEAN Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 121. ASEAN Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 122. ASEAN Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 123. ASEAN Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. ASEAN Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 125. ASEAN Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 126. ASEAN Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 127. GCC Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. GCC Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 129. GCC Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 130. GCC Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 131. GCC Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. GCC Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. GCC Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 134. GCC Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 135. European Union Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. European Union Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 137. European Union Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 138. European Union Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 139. European Union Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. European Union Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. European Union Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. European Union Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 143. BRICS Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. BRICS Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 145. BRICS Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 146. BRICS Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 147. BRICS Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. BRICS Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. BRICS Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 150. BRICS Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 151. G7 Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. G7 Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 153. G7 Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 154. G7 Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 155. G7 Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 156. G7 Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. G7 Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 158. G7 Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 159. NATO Antifungal Drugs for Skin Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. NATO Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 161. NATO Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 162. NATO Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 163. NATO Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. NATO Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. NATO Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 166. NATO Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 167. Global Antifungal Drugs for Skin Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. United States Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 169. United States Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 170. United States Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 171. United States Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 172. United States Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. United States Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 174. United States Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 175. United States Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 176. Canada Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 177. Canada Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 178. Canada Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 179. Canada Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 180. Canada Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. Canada Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Canada Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 183. Canada Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 184. Mexico Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 185. Mexico Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 186. Mexico Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 187. Mexico Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 188. Mexico Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. Mexico Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Mexico Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 191. Mexico Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 192. Brazil Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 193. Brazil Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 194. Brazil Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 195. Brazil Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 196. Brazil Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. Brazil Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. Brazil Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 199. Brazil Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 200. United Kingdom Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 201. United Kingdom Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 202. United Kingdom Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 203. United Kingdom Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 204. United Kingdom Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. United Kingdom Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. United Kingdom Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 207. United Kingdom Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 208. Germany Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 209. Germany Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 210. Germany Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 211. Germany Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 212. Germany Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 213. Germany Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. Germany Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 215. Germany Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 216. France Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 217. France Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 218. France Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 219. France Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 220. France Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. France Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 222. France Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 223. France Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 224. Russia Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 225. Russia Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 226. Russia Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 227. Russia Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 228. Russia Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. Russia Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 230. Russia Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 231. Russia Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 232. Italy Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 233. Italy Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 234. Italy Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 235. Italy Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 236. Italy Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. Italy Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 238. Italy Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 239. Italy Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 240. Spain Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 241. Spain Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 242. Spain Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 243. Spain Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 244. Spain Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Spain Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. Spain Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 247. Spain Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 248. China Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 249. China Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 250. China Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 251. China Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 252. China Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 253. China Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 254. China Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 255. China Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 256. India Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 257. India Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 258. India Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 259. India Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 260. India Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 261. India Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 262. India Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 263. India Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 264. Japan Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 265. Japan Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 266. Japan Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 267. Japan Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 268. Japan Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. Japan Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Japan Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 271. Japan Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 272. Australia Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 273. Australia Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 274. Australia Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 275. Australia Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 276. Australia Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. Australia Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. Australia Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 279. Australia Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 280. South Korea Antifungal Drugs for Skin Market Size, 2017-2032 (USD Million)
TABLE 281. South Korea Antifungal Drugs for Skin Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 282. South Korea Antifungal Drugs for Skin Market Size, by Azoles, 2017-2032 (USD Million)
TABLE 283. South Korea Antifungal Drugs for Skin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 284. South Korea Antifungal Drugs for Skin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 285. South Korea Antifungal Drugs for Skin Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 286. South Korea Antifungal Drugs for Skin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 287. South Korea Antifungal Drugs for Skin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 288. Global Antifungal Drugs for Skin Market Share, by Key Player, 2025
TABLE 289. Global Antifungal Drugs for Skin Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Astellas Pharma Inc
  • Bausch Health Companies Inc
  • Bayer AG
  • Cipla Ltd
  • Dr. Reddy’s Laboratories Ltd
  • GlaxoSmithKline plc
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • Sandoz International GmbH
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc

Related Topics

Related Reports

AntiFungal Drugs Market Outlook, 2030 - Product Image

AntiFungal Drugs Market Outlook, 2030

  • Report
  • 193 Pages
  • Global
From
AntiFungal Drugs Market Overview, 2025-2030 - Product Image

AntiFungal Drugs Market Overview, 2025-2030

  • Report
  • 101 Pages
  • Global
From
Topical Antifungals Market Report 2026 - Product Image

Topical Antifungals Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Antifungal Treatment - Global Strategic Business Report - Product Image

Antifungal Treatment - Global Strategic Business Report

  • Report
  • 590 Pages
  • Global
From
Antifungal Drugs - Global Strategic Business Report - Product Image

Antifungal Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.